RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Clinical trial NCT06987513 · COMPLETED

Trial details

NCT number: NCT06987513
Sponsor: Altimmune, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Use Disorder (AUD)

Start date: 2025-05-15
Primary completion: 2026-07-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.